Cardiac Development Long non-coding RNA (CARDEL) is activated during human heart development and contributes to cardiac specification and homeostasis
Isabela Tiemy PereiraiD, Rubens Gomes-JúnioriD, Aruana Hansel-FroseiD, Rhaíza S. V. FrançaiD, Man LiuiD, Hossam A. N. SolimaniD, Sunny Sun-Kin ChaniD, Samuel C. DudleyiD, Michael KybaiD, Bruno DallagiovannaiD
Abstract
Successful heart development depends on the careful orchestration of a network of transcription factors and signaling pathways. In recent years, the in vitro cardiac differentiation using human pluripotent stem cells (hPSCs) has been used to uncover the intricate gene network regulation involved in the proper formation and function of the human heart. Here, we searched for uncharacterized cardiac developmental genes by combining a temporal evaluation of the human cardiac specification in vitro with the analysis of fetal and adult heart tissue gene expression. We discovered that CARDEL (CARdiac DEvelopment Long non-coding RNA; LINC00890; SERTM2) expression coincides with the commitment to the cardiac lineage. CARDEL knockout hPSCs differentiated poorly in cardiac cells, and hPSC-derived cardiomyocytes showed faster beating rates after CARDEL controlled overexpression during differentiation. Altogether, we demonstrate physiological and molecular evidence that CARDEL expression contributes to sculpting the cardiac program during cell-fate commitment.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 0.27
- Field percentile
- 45th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Minimal in vivo requirements for developmentally regulated cardiac long intergenic non-coding RNAs
Matthew George, Qiming Duan, … Benoit G. Bruneau·DevelopmentPeer-reviewed·Nov 29, 2019
- Long noncoding RNA HSCHARME is altered in human cardiomyopathies and promotes stem cell-derived cardiomyocyte differentiation by splicing regulation.
Giulia Buonaiuto, Fabio Desideri, … Monica Ballarino·bioRxiv·Nov 6, 2024
- Long noncoding RNA VENTHEART is required for cardiomyocyte specification and function
A. Dashi, T. W. Lek Wen, … R. Foo·bioRxiv·Feb 1, 2021
- SHEN-LONG, a novel cardiac regulatory locus, regulates cardiac master transcription factor NKX2-5 in pluripotent stem cell derived cardiomyocytes
María Agustina Scarafia, Julia Halek, … Alejandro La Greca·bioRxiv·Dec 24, 2024
- The level of HAND1 controls the specification of multipotent cardiac and extraembryonic progenitors
Adam T Lynch, Naomi Phillips, … Matthew J. Birket·bioRxiv·Aug 15, 2024
- Retinoic acid signaling modulation guides in vitro specification of human heart field-specific progenitor pools
D. Zawada, J. Kornherr, … A. Goedel·bioRxiv·May 30, 2022